That is very important, due to the fact that the method a protein in the human body folds determines if a pharmaceutical will have the ability to bind to that protein and be efficient. Simply put, we have to understand how these proteins fold if we desire a drug to work. Historically, this has been an experimental process (jeff brown genome sequencing). Now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're designed to do. This was an advancement practically no one discovered. But it's going to have extensive implications for treating illness. I forecast that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be a lot of investment opportunities in this space, too. Shifting topics It's going to be a great year for bitcoin. I'm bullish on it in 2021 (jeff brown 2020 predictions). That stated, I still think bitcoin will continue to be unstable. We're close to all-time highs. I would not be amazed if it pulled back maybe considerably prior to going higher - first lady. I have actually been covering bitcoin for a long period of time now. One of the first research study reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial suggestion, I entitled my report "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time. We were primarily informing readers. However that's not the big concern anymore. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche business. Mass, Mutual is a trusted 170-year-old organization. So believe about that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a big reason I'm bullish on it this year. white house. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These business raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I predict 2021 will be another record year in IPOs. There are so lots of excellent personal companies on the edge of hitting the general public markets And I've been working on a new way for you to invest even before these companies go public.
This opportunity has actually been developing over the last couple of years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to learn all the information. Go right here to reserve your area free of charge.
Emma Walsh here, handling editor of the Diary. Regular Diary readers know that tech isn't our usual beat (diplomatic relations). And when it pertains to tech investing, we leave it to the professionals. The good news is, we have a number of such specialists in our Rolodex. Our associate Jeff Brown will be familiar to our long time readers. He is among the most accomplished tech investing professionals we know (melania trump). In truth, he had numerous triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take a look at the big image and anticipate what's simply around the corner.
That includes things like 5G networks, biotech, synthetic intelligence, and far more. These trends are experiencing rapid development and developing extraordinary opportunities for financiers. I want to make sure all our readers are prepared for what's next. And with that in mind, let me draw the image of what I see can be found in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a topic I have actually been covering for years now. last week. However despite what numerous readers may think, this is a pattern that's simply starting. Despite the fact that the COVID-19 pandemic interrupted supply chains last year, an outstanding 250 million 5G-enabled gadgets were still sold.
And all of this eventually led to Apple delaying the release of the 5G-enabled i, Phone 12 by two months (jeff brown genome sequencing stock). Losing two months of production and sales truly impacts how numerous 5G devices are sold in the fiscal year. When you think about all of that, selling 250 million units is remarkable. More notably, the hold-ups brought on by the pandemic produced a ton of bottled-up need. And that demand is now going to be pushed into 2021. In truth, I predict that more than 500 million 5G devices will be shipped in 2021 - united arab emirates. Which's not my only 5G prediction When I have actually discussed 5G in the past, I have actually described its 3 various stages.
In Stage Two, 5G gadgets go on sale. 5G phones and other items start to reach consumers. And in Stage Three, 5G services begin to be provided (jeff brown top biotech stock 2021). That's when we begin to see applications operating on 5G networks. Think about things like huge multiplayer video games over a cellphone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will begin Phase Three by this summer. This starts something of a virtuous cycle: A lot of individuals do not really appreciate the technology. But they will care if there are amazing applications that can just be accessed with a 5G phone.
That leads to more 5G apps being developed. In fact, 5G is going to open up a suite of extraordinary applications: self-driving vehicles, the Internet of Things, robotic surgery, and more. All of these innovations need 5G. The investment opportunities going forward will be enormous. Stepping away from 5G, the next essential technology I foresee in 2021 is CRISPR hereditary modifying. CRISPR means "clustered regularly interspaced brief palindromic repeat." It's a mouthful. However it's one of the most amazing advancements in biotechnology. At a high level, CRISPR is an innovation that can modify our genetic makeup as if it were software application.
The program can crash or not operate properly. CRISPR utilizes a similar idea but with our genetic code. "Typos" in our genome can lead to illness. CRISPR can fix these "typos." For many years, CRISPR was mostly a specific niche innovation that wasn't well comprehended. And throughout that time, there were truly only 3 business running in this space. However things are altering. CRISPR is no longer simply theoretical. We're seeing actual outcomes. We're dealing with diseases and seeing that this innovation simply works. And as a result, a "second crop" of early-stage CRISPR business is going public and providing incredible returns. This entire market is efficiently a greenfield chance.
There's room for lots of business to exist in this area. jeff brown. And there will be more. That's my forecast for CRISPR in 2021. I predict that 2 or 3 more genetic modifying business will hold their IPOs. Sticking with biotechnology, we are seeing amazing things taking place at the convergence of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its newest Alpha, Fold software application can accurately anticipate the folding of a protein based solely on its amino acid sequence with 92. 4% precision. That's crucial because the way a protein in the body folds identifies if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has been a trial-and-error process. Today, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're designed to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one but several drug therapies produced utilizing this technology. This was among those developments that almost no one noticed. But it's going to have extensive ramifications for treating illness. And, naturally, there will be plenty of investment opportunities in this area, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be amazed if it drew back possibly substantially prior to going greater. I've been covering bitcoin for a long time now. One of the very first research reports I ever published was on bitcoin - jeff brown genome sequencing stock. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for anyone who followed my suggestion. But at the time of that initial recommendation, I titled my report, "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time.
But no one is asking that question any longer. Now, we're seeing institutional cash finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. jeff brown genome sequencing stock. Mass, Mutual is a 150-year-old institution. So think of that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge factor why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another reward forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and declares the information depends on date as of February 2021, but we might not individually validate this claim. Given Jeff Brown's past, he likely has a considerable net worth, however we can't hammer down an exact figure at this moment. Brown is best understood for his sage-like capability to choose winning innovation stocks. He spent more than 25 years looking into innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience provides him an outstanding viewpoint on the market. He's always on the hunt for new chances, and he shares many of his finest choices in the Future Report.
That's high appreciation, however it's not ridiculously reasoned. Brown has an exceptional reputation as a stock-picker, and he successfully anticipated a few of the biggest economic events of the past twenty years. Although he doesn't appear to release his picks to the general public, the service's success is a direct sign of Brown's stock-picking prowess. Nobody on Wall Street gets it right every time, however Jeff Brown's precise forecasts have made him legions of dedicated followers. That says a lot about his ability. The Near Future Report is released by Brownstone Research, a prominent financial research publisher. Brownstone Research study offers a number of research services with a wide array of expertises - tech predictions.
The company is also connected with Bonner & Partners, another well-respected research publisher - united arab emirates. On its site, Brownstone states its mission is to supply retail investors with professional-grade research study: "For too long, the finest financial investment research study has actually not been readily available to individual financiers. It has actually been typically booked for investment banks, hedge funds, personal equity, and high-net-worth customers. tech stocks. The objective of Brownstone Research is to make that type of proprietary research offered to any investors seeking to get an edge in the markets. The objective is simple to deliver special and rewarding financial investment research study found nowhere else." -Brownstone Research study site excerpt from the Jeff Brown is the founder of Brownstone Research study, and he likewise works as the company's Chief Financial investment Expert.
With Brown directing the ship, Brownstone Research is a powerhouse publisher with lots to provide its clients. After years of steady success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a home name throughout many of America. If you know even a little bit about the marketplace, you understand that he has a reputation as a King Midas of sorts. tech stocks. Everything he touches relies on gold! Jeff is well conscious of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big task.
In reality, Brown believes S.A.V. jeff brown biotech pick. could be "the greatest trend of the 2020s, and he's not alone. Have a look at these quotes from other popular S.A.V. bulls: Elon's next big act will be weding 2 advanced innovations: synthetic intelligence and electric cars and trucks. Musk hopes the mix will assist him establish the first fully-autonomous, self-driving cars ever. It's absolutely nothing brief of the automobile industry's Holy Grail. As you know, electric cars and self-driving vehicle stocks have actually been big this year, but the Wall Street maker has actually approved buzz without much tangible outcome. Regardless of an extreme increase in competition over the previous couple of years, Brown still thinks Musk has the best possibility of putting it all together.
tech might be the magic string that ties everything together. S.A.V. stands for Shared Autonomous Vehicle, and it might be the future of transportation. Basically, this innovation would allow you to lease your cars and truck as a self-governing, self-driving taxi when you're not utilizing it. You simply get out of the automobile and press a button on an app that tells the car to "sign up with the fleet." Next thing you understand, you're unwinding on your sofa while your vehicle shuttles ride-sharers around town. Best of all, you get to keep a hefty piece of the revenues. It sounds crazy, but it might be closed than you think.